<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>WBC-Reduced Components | Blood Bank</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="This section focuses on a crucial modification applied to cellular blood components: Leukocyte Reduction. This process involves removing the vast majority of white blood cells (WBCs or leukocytes)...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="WBC-Reduced Components | Blood Bank">
<meta property="og:type" content="book">
<meta property="og:description" content="This section focuses on a crucial modification applied to cellular blood components: Leukocyte Reduction. This process involves removing the vast majority of white blood cells (WBCs or leukocytes)...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="WBC-Reduced Components | Blood Bank">
<meta name="twitter:description" content="This section focuses on a crucial modification applied to cellular blood components: Leukocyte Reduction. This process involves removing the vast majority of white blood cells (WBCs or leukocytes)...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Blood Bank</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Blood Products</li>
<li><a class="" href="donors.html">Donors</a></li>
<li><a class="" href="qualification.html">Qualification</a></li>
<li><a class="" href="processing.html">Processing</a></li>
<li><a class="" href="adverse-reactions-1.html">Adverse Reactions</a></li>
<li><a class="" href="special-donations-1.html">Special Donations</a></li>
<li><a class="" href="processing-1.html">Processing</a></li>
<li><a class="" href="fda-aabb-requirements.html">FDA, AABB Requirements</a></li>
<li><a class="" href="testing.html">Testing</a></li>
<li><a class="" href="labeling.html">Labeling</a></li>
<li><a class="" href="storage.html">Storage</a></li>
<li><a class="" href="anticoagulantsadditives.html">Anticoagulants/Additives</a></li>
<li><a class="" href="temperature-requirements.html">Temperature Requirements</a></li>
<li><a class="" href="transportation.html">Transportation</a></li>
<li><a class="" href="stored-products.html">Stored Products</a></li>
<li><a class="" href="expiration.html">Expiration</a></li>
<li><a class="" href="blood-components.html">Blood Components</a></li>
<li><a class="" href="red-blood-cells.html">Red Blood Cells</a></li>
<li><a class="" href="cryoprecipitated-ahf.html">Cryoprecipitated AHF</a></li>
<li><a class="" href="platelets.html">Platelets</a></li>
<li><a class="" href="plasma.html">Plasma</a></li>
<li><a class="" href="granulocytes.html">Granulocytes</a></li>
<li><a class="active" href="wbc-reduced-components.html">WBC-Reduced Components</a></li>
<li><a class="" href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></li>
<li><a class="" href="apheresis-products.html">Apheresis Products</a></li>
<li><a class="" href="fractionation-products.html">Fractionation Products</a></li>
<li><a class="" href="whole-blood.html">Whole Blood</a></li>
<li><a class="" href="washed-rbcs.html">Washed RBCs</a></li>
<li><a class="" href="rejuvenated-rbcs.html">Rejuvenated RBCs</a></li>
<li><a class="" href="irradiated-components.html">Irradiated Components</a></li>
<li><a class="" href="hematopoietic-progenitors.html">Hematopoietic Progenitors</a></li>
<li><a class="" href="blood-component-qc.html">Blood Component QC</a></li>
<li class="book-part">Blood Group Systems</li>
<li><a class="" href="genetics.html">Genetics</a></li>
<li><a class="" href="basic.html">Basic</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="blood-group-inheritance.html">Blood Group Inheritance</a></li>
<li><a class="" href="biochemistryantigens.html">Biochemistry/Antigens</a></li>
<li><a class="" href="abo.html">ABO</a></li>
<li><a class="" href="lewis.html">Lewis</a></li>
<li><a class="" href="rh.html">Rh</a></li>
<li><a class="" href="mns.html">MNS</a></li>
<li><a class="" href="p1pkglobosidep.html">P1PK/Globoside(P)</a></li>
<li><a class="" href="ii.html">Ii</a></li>
<li><a class="" href="kell.html">Kell</a></li>
<li><a class="" href="kidd.html">Kidd</a></li>
<li><a class="" href="duffy.html">Duffy</a></li>
<li><a class="" href="lutheran.html">Lutheran</a></li>
<li><a class="" href="other-blood-groups.html">Other Blood Groups</a></li>
<li><a class="" href="high-prevalence-antigens.html">High Prevalence Antigens</a></li>
<li><a class="" href="low-prevalence-antigens.html">Low Prevalence Antigens</a></li>
<li><a class="" href="hla.html">HLA</a></li>
<li><a class="" href="platelet-specific.html">Platelet-Specific</a></li>
<li><a class="" href="granulocyte-specific.html">Granulocyte-Specific</a></li>
<li><a class="" href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></li>
<li><a class="" href="immunogenicity.html">Immunogenicity</a></li>
<li><a class="" href="antigen-prevalence.html">Antigen Prevalence</a></li>
<li class="book-part">Immunology &amp; Physiology</li>
<li><a class="" href="immunology.html">Immunology</a></li>
<li><a class="" href="immune-response.html">Immune response</a></li>
<li><a class="" href="primary-secondary.html">Primary &amp; Secondary</a></li>
<li><a class="" href="b-t-cells-macrophages.html">B &amp; T cells, Macrophages</a></li>
<li><a class="" href="genetics-1.html">Genetics</a></li>
<li><a class="" href="immunoglobulins.html">Immunoglobulins</a></li>
<li><a class="" href="classes-subclasses.html">Classes &amp; Subclasses</a></li>
<li><a class="" href="structure.html">Structure</a></li>
<li><a class="" href="properties.html">Properties</a></li>
<li><a class="" href="ag-ab-interactions.html">Ag-Ab Interactions</a></li>
<li><a class="" href="principles.html">Principles</a></li>
<li><a class="" href="testing-1.html">Testing</a></li>
<li><a class="" href="complement.html">Complement</a></li>
<li><a class="" href="pathway-mechanisms.html">Pathway Mechanisms</a></li>
<li><a class="" href="biologic-properties.html">Biologic Properties</a></li>
<li><a class="" href="physiology-pathophysiology.html">Physiology &amp; Pathophysiology</a></li>
<li><a class="" href="blood-physiology.html">Blood Physiology</a></li>
<li><a class="" href="circulation-volume.html">Circulation &amp; Volume</a></li>
<li><a class="" href="composition-function.html">Composition &amp; Function</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="wbc-reduced-components" class="section level1 unnumbered">
<h1>WBC-Reduced Components<a class="anchor" aria-label="anchor" href="#wbc-reduced-components"><i class="fas fa-link"></i></a>
</h1>
<p>This section focuses on a crucial modification applied to cellular blood components: <strong>Leukocyte Reduction</strong>. This process involves removing the vast majority of white blood cells (WBCs or leukocytes) from Red Blood Cell (RBC) and Platelet units before transfusion. It has become a standard of practice in many parts of the world due to its significant benefits in reducing certain transfusion-related complications</p>
<div id="what-are-leukocyte-reduced-components" class="section level2 unnumbered">
<h2>
<strong>What are Leukocyte-Reduced Components?</strong><a class="anchor" aria-label="anchor" href="#what-are-leukocyte-reduced-components"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> Blood components (primarily RBCs and Platelets) that have undergone a process to significantly decrease the number of contaminating leukocytes (WBCs) present in the final product</li>
<li>
<strong>Goal:</strong> To minimize the adverse effects associated with transfusing donor WBCs along with the intended therapeutic cells (RBCs or platelets)</li>
</ul>
</div>
<div id="why-leukoreduce-rationale-benefits" class="section level2 unnumbered">
<h2>
<strong>Why Leukoreduce? (Rationale &amp; Benefits)</strong><a class="anchor" aria-label="anchor" href="#why-leukoreduce-rationale-benefits"><i class="fas fa-link"></i></a>
</h2>
<p>Transfusing donor leukocytes can lead to several undesirable outcomes. Leukoreduction aims to mitigate these risks:</p>
<ul>
<li>****Reduce Febrile Non-Hemolytic Transfusion Reactions (FNHTRs):** This is one of the most common transfusion reactions. It’s often caused by:
<ul>
<li>Cytokines (like IL-1, IL-6, TNF-α) released by WBCs accumulating <em>during storage</em>
</li>
<li>Recipient antibodies reacting against donor HLA antigens or other antigens present on the transfused WBCs</li>
<li>
<em>Benefit:</em> Removing WBCs significantly reduces the cytokine load and the antigenic stimulus, thus lowering the incidence of FNHTRs</li>
</ul>
</li>
<li>****Reduce/Prevent HLA Alloimmunization:** Exposure to foreign HLA antigens present on donor leukocytes can cause the recipient to develop HLA antibodies. This is particularly problematic for:
<ul>
<li>Patients requiring long-term platelet support (can lead to platelet refractoriness)</li>
<li>Patients awaiting organ or hematopoietic progenitor cell (HPC) transplantation (can complicate matching and increase rejection risk)</li>
<li>
<em>Benefit:</em> Reducing the number of transfused WBCs decreases the recipient’s exposure to foreign HLA antigens, lowering the risk of developing HLA antibodies</li>
</ul>
</li>
<li>****Reduce Risk of Transmitting Cell-Associated Viruses:** Certain viruses, most notably <strong>Cytomegalovirus (CMV)</strong>, primarily reside within leukocytes
<ul>
<li>
<em>Benefit:</em> Removing WBCs significantly reduces the amount of transmissible CMV. Leukoreduction is considered largely equivalent to providing CMV-seronegative blood (“CMV safe”) for preventing transfusion-transmitted CMV infection, especially for RBCs. (Note: For highest-risk patients like CMV-negative transplant recipients receiving cells from a CMV-positive donor, CMV-seronegative units might still be preferred by some clinicians if available.)</li>
</ul>
</li>
<li>****Potential Other Benefits (Less definitively proven or primary indications)**
<ul>
<li>May reduce transfusion-associated immunomodulation (TRIM) - the subtle immunosuppressive effects sometimes attributed to transfusion</li>
<li>May reduce transmission of certain bacteria that can be carried by WBCs</li>
</ul>
</li>
</ul>
</div>
<div id="how-is-leukoreduction-achieved-methods" class="section level2 unnumbered">
<h2>
<strong>How is Leukoreduction Achieved? (Methods)</strong><a class="anchor" aria-label="anchor" href="#how-is-leukoreduction-achieved-methods"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Filtration:</strong> This is the most common method
<ul>
<li>
<strong>Pre-storage Leukoreduction (Preferred Method):</strong> Filtration occurs at the <strong>blood collection center</strong> shortly after collection, <em>before</em> the component is stored. This is typically done using specialized filters integrated into the blood collection set or attached via sterile connection devices
<ul>
<li>
<em>Advantages:</em> Removes WBCs before significant cytokine accumulation occurs; allows for better quality control by the blood center</li>
</ul>
</li>
<li>
<strong>Post-storage / Laboratory Leukoreduction:</strong> Filtration occurs in the <strong>hospital transfusion service laboratory</strong> just before the unit is issued. Less common now for routine LR</li>
<li>
<strong>Bedside Leukoreduction:</strong> Filtration occurs during transfusion using a specific <strong>leukoreduction filter</strong> at the patient’s bedside
<ul>
<li>
<em>Disadvantages:</em> Less effective at preventing FNHTRs caused by pre-formed cytokines; quality control is more variable; requires specific bedside filters distinct from standard blood filters</li>
</ul>
</li>
</ul>
</li>
<li>****Apheresis Collection:** Many modern apheresis instruments are designed to collect platelet products (and sometimes RBCs) that are already significantly leukocyte-reduced as part of the automated collection process</li>
<li>****Buffy Coat Removal (Less Common in North America):** A processing method used in some regions where the WBC-rich buffy coat layer is physically removed during component preparation</li>
</ul>
</div>
<div id="standards-and-quality-control" class="section level2 unnumbered">
<h2>
<strong>Standards and Quality Control</strong><a class="anchor" aria-label="anchor" href="#standards-and-quality-control"><i class="fas fa-link"></i></a>
</h2>
<p>To be labeled as “Leukocytes Reduced,” a component must meet defined standards for residual WBC content:</p>
<ul>
<li>
<strong>AABB / US Standard:</strong> Residual WBC count must be <strong>&lt; 5 x 10⁶</strong> per final component (for RBCs and apheresis platelets)</li>
<li>
<strong>Council of Europe Standard:</strong> Often stricter, requiring <strong>&lt; 1 x 10⁶</strong> residual WBCs per final component</li>
<li>
<strong>Quality Control:</strong> Blood centers must perform regular QC testing on a sample of units to ensure their leukoreduction processes consistently meet these standards</li>
</ul>
</div>
<div id="which-components-are-leukoreduced" class="section level2 unnumbered">
<h2>
<strong>Which Components are Leukoreduced?</strong><a class="anchor" aria-label="anchor" href="#which-components-are-leukoreduced"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li><strong>Red Blood Cells (RBCs)</strong></li>
<li>
<strong>Platelets:</strong> (both Apheresis/SDP and pooled WBD units)</li>
</ul>
<p><strong>Note:</strong> Plasma and Cryoprecipitate are essentially leukocyte-free due to the centrifugation processes used in their preparation, so leukoreduction is not applicable. Granulocytes are <em>never</em> leukoreduced, as leukocytes are the intended therapeutic component</p>
</div>
<div id="usage-universal-vs.-indicated-leukoreduction" class="section level2 unnumbered">
<h2>
<strong>Usage: Universal vs. Indicated Leukoreduction</strong><a class="anchor" aria-label="anchor" href="#usage-universal-vs.-indicated-leukoreduction"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Universal Leukoreduction (ULR):</strong> This is the standard practice in many developed countries (including the US, Canada, UK, etc.). <strong>Nearly all cellular components (RBCs, Platelets) are leukoreduced for all patients.</strong> This approach simplifies inventory management and ensures the benefits are provided broadly without needing specific physician orders for LR</li>
<li>
<strong>Indicated Leukoreduction:</strong> In regions without ULR, leukoreduction might be specifically ordered for patients with known indications (e.g., history of FNHTRs, transplant candidates, chronically transfused patients)</li>
</ul>
</div>
<div id="impact-on-product" class="section level2 unnumbered">
<h2>
<strong>Impact on Product</strong><a class="anchor" aria-label="anchor" href="#impact-on-product"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Expiration Date:</strong> If performed using a <strong>closed system</strong> (e.g., pre-storage filtration, sterile connection), leukoreduction <strong>does not change the original expiration date</strong> of the component</li>
<li>
<strong>Cell Loss:</strong> There is a minimal loss of RBCs or platelets during the filtration process, but it’s generally not considered clinically significant</li>
<li>
<strong>Cost:</strong> Leukoreduction adds a small incremental cost to the blood component due to the filter and processing</li>
</ul>
</div>
<div id="key-terms-17" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-17"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Leukocyte (WBC):</strong> White blood cell</li>
<li>
<strong>Leukoreduction (LR):</strong> The process of removing leukocytes from cellular blood components</li>
<li>
<strong>Febrile Non-Hemolytic Transfusion Reaction (FNHTR):</strong> A common reaction characterized by fever, chills, and sometimes rigors, not caused by red cell destruction</li>
<li>
<strong>HLA Alloimmunization:</strong> Development of antibodies against Human Leukocyte Antigens from a non-self source (like a transfusion)</li>
<li>
<strong>Platelet Refractoriness:</strong> Poor platelet count increment after transfusion, often due to HLA antibodies</li>
<li>
<strong>Cytokines:</strong> Signaling proteins released by cells (including WBCs) that mediate inflammation and immune responses</li>
<li>
<strong>CMV (Cytomegalovirus):</strong> A virus commonly transmitted via leukocytes</li>
<li>
<strong>Pre-storage Leukoreduction:</strong> Removal of WBCs at the blood center before storage (preferred method)</li>
<li>
<strong>Bedside Leukoreduction:</strong> Removal of WBCs during transfusion using a bedside filter (least preferred method)</li>
<li>
<strong>Universal Leukoreduction (ULR):</strong> Policy of providing leukoreduced components to essentially all patients</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();
  
  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase" 
          && 
          !elem.classList
          .contains('book-part') 
          ? l.push(elem) 
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="granulocytes.html">Granulocytes</a></div>
<div class="next"><a href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#wbc-reduced-components">WBC-Reduced Components</a></li>
<li><a class="nav-link" href="#what-are-leukocyte-reduced-components">What are Leukocyte-Reduced Components?</a></li>
<li><a class="nav-link" href="#why-leukoreduce-rationale-benefits">Why Leukoreduce? (Rationale &amp; Benefits)</a></li>
<li><a class="nav-link" href="#how-is-leukoreduction-achieved-methods">How is Leukoreduction Achieved? (Methods)</a></li>
<li><a class="nav-link" href="#standards-and-quality-control">Standards and Quality Control</a></li>
<li><a class="nav-link" href="#which-components-are-leukoreduced">Which Components are Leukoreduced?</a></li>
<li><a class="nav-link" href="#usage-universal-vs.-indicated-leukoreduction">Usage: Universal vs. Indicated Leukoreduction</a></li>
<li><a class="nav-link" href="#impact-on-product">Impact on Product</a></li>
<li><a class="nav-link" href="#key-terms-17">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/blob/main/Rmd/01-D-06.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/edit/main/Rmd/01-D-06.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3" style="text-align: center; flex: 100%; max-width: 100%;">
    <p>Written by Brett M. Rice | Updated 2025-04-04 | Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div>

  <!--div class="col-12 col-md-6 mt-3">
    <p>Built by the <a class="text-light" href="https://bookdown.org">bookdown</a> R package</p>
  </div-->

</div></div>
</footer>
</body>
</html>
